Literature DB >> 1318126

Cytokines, receptors, and inhibitors.

G Gehr1, T Braun, W Lesslauer.   

Abstract

Cytokines are endogenous mediators in inflammatory and immunologic host defense reactions. In various diseases cytokines produced in excess cause systemic or local toxic effects. Cytokines therefore are tightly controlled by regulation of their biosynthesis and release and by counteracting mechanisms which limit their activities. Two new cytokine inhibitory mechanisms have recently been discovered. First, the generation of soluble receptors which compete with cellular receptors for cytokine binding has been recognized as a general phenomenon. Second, a receptor antagonist polypeptide binding to the receptor but not eliciting biological activity has been discovered in the IL-1 system. These polypeptides, when expressed in various recombinant forms, are not only research tools but may find also direct clinical use.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318126     DOI: 10.1007/bf00422944

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  52 in total

Review 1.  Two distinct tumour necrosis factor receptors--members of a new cytokine receptor gene family.

Authors:  H Loetscher; M Brockhaus; Z Dembic; R Gentz; U Gubler; H P Hohmann; H W Lahm; A P Van Loon; Y C Pan; E J Schlaeger
Journal:  Oxf Surv Eukaryot Genes       Date:  1991

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Oxpentifylline in endotoxaemia.

Authors:  P Zabel; D T Wolter; M M Schönharting; U F Schade
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

4.  Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities.

Authors:  P Seckinger; E Vey; G Turcatti; P Wingfield; J M Dayer
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

5.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

Authors:  M Kriegler; C Perez; K DeFay; I Albert; S D Lu
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

6.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor.

Authors:  W C Fanslow; J E Sims; H Sassenfeld; P J Morrissey; S Gillis; S K Dower; M B Widmer
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).

Authors:  H P Hohmann; R Remy; M Brockhaus; A P van Loon
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

Review 9.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

10.  Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography.

Authors:  D Novick; H Engelmann; D Wallach; O Leitner; M Revel; M Rubinstein
Journal:  J Chromatogr       Date:  1990-06-27
View more
  3 in total

1.  Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.

Authors:  Artur Bauhofer; Alexander Torossian; Wilfried Lorenz; Martin Middeke; Ulrike Plaul; Philipp Schütz; Benno Stinner; Markus Hattel; Ilhan Celik
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

2.  Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis.

Authors:  S de Kossodo; G E Grau; J A Louis; I Müller
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

3.  Cytokine soluble receptors in perinatal and early neonatal life.

Authors:  Efthimia Protonotariou; Demetrios Rizos; Ariadne Malamitsi-Puchner; Evangelia Moira; Angeliki Sarandakou; Emmanuil Salamalekis
Journal:  Mediators Inflamm       Date:  2003-06       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.